Example: Heart Attack

Search clinical trials for: Trientine

Total 20 results

NCT01472874

Completed

Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease

Conditions: Wilson Disease
NCT01874028

Completed

A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

Conditions: Wilson's Disease
NCT03299829

Completed

A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients

Conditions: Trientine Treatment for Wilson's Disease
NCT04706429

Not yet recruiting

The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy

Conditions: Hypertrophic Cardiomyopathy
NCT01295073

Withdrawn

Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus

Conditions: Macular Edema Following Cataract Surgery
NCT01213888

Terminated

Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy

Conditions: Diabetic Retinopathy
NCT02068079

Withdrawn

A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma

Conditions: Melanoma
NCT03480750

Completed

Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer

Conditions: Ovarian Neoplasms Malignant (Excl Germ Cell); Peritoneal Carcinoma; Fallopian Tube Cancer
NCT02426905

Unknown status

Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine

Conditions: Wilson Disease
NCT01178112

Completed

Trientine and Carboplatin in Advanced Malignancies

Conditions: Advanced Cancers
NCT03539952

Active, not recruiting

Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease

Conditions: Wilson Disease
NCT00004339

Completed

Study of Tetrathiomolybdate in Patients With Wilson Disease

Conditions: Wilson Disease
NCT04170348

Recruiting

Daily Vitamin D for Sickle-cell Respiratory Complications

Conditions: Sickle Cell Disease; Anemia, Sickle Cell; Anemia, Hemolytic, Congenital; Respiratory Tract Diseases; Respiration Disorders; Acute Chest Syndrome; Lung Diseases; Asthma; Respiratory Tract Infections; Nutrition Disorders; Deficiency Diseases Vitamin; Vitamin D Deficiency
NCT02763215

Completed

The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment

Conditions: Wilson Disease
NCT03403205

Active, not recruiting

Efficacy and Safety of ALXN1840 (Formerly Named WTX101) Administered for 48 Weeks Versus Standard of Care in Patients With Wilson Disease With an Extension Period of up to 60 Months

Conditions: Wilson Disease
NCT02553447

Recruiting

Cholecalciferol in Treating Patients With Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

Conditions: Chronic Lymphocytic Leukemia; Non-Hodgkin Lymphoma; Untreated Chronic Lymphocytic Leukemia; Vitamin D Deficiency
NCT01787409

Recruiting

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

Conditions: Aggressive Non-Hodgkin Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-Cell Lymphoma; Chronic Lymphocytic Leukemia; Diffuse Large B-Cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Hepatosplenic T-Cell Lymphoma; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Mediastinal (Thymic) Large B-Cell Lymphoma; Nasal Type Extranodal NK/T-Cell Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Primary Cutaneous Anaplastic Large Cell Lymphoma; Refractory Anaplastic Large Cell Lymphoma; Small Lymphocytic Lymphoma; Subcutaneous Panniculitis-Like T-Cell Lymphoma
NCT02877641

Terminated

Cholecalciferol Supplementation in Strengthening Inspiratory Muscles in Cholecalciferol-Deficient Patients With Chronic Obstructive Pulmonary Disease

Conditions: Chronic Obstructive Pulmonary Disease; Muscle Weakness
NCT01325311

Completed

Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer

Conditions: Prostate Adenocarcinoma; Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer
NCT00887432

Completed

Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation

Conditions: Prostate Adenocarcinoma